{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:39:45Z","timestamp":1777599585535,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.arcmed.2012.05.006","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T07:33:25Z","timestamp":1339572805000},"page":"294-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["No Effect of Antidepressant Treatment on Elevated Serum Ceruloplasmin Level in Patients with First-Episode Depression: A Longitidunal Study"],"prefix":"10.1016","volume":"43","author":[{"given":"Mehmet Cemal","family":"Kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasin","family":"Bez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"Selek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Fatih Karababa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haluk A.","family":"Sava\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakim","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Herken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2012.05.006_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/B:MEBR.0000043973.10494.85","article-title":"Pathophysiology and clinical features of Wilson\u2019s disease","volume":"19","author":"Ferenci","year":"2004","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.arcmed.2012.05.006_bib2","doi-asserted-by":"crossref","first-page":"14773","DOI":"10.1074\/jbc.271.25.14773","article-title":"Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism","volume":"271","author":"Mukhopadhyay","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2012.05.006_bib3","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0006-2952(00)00399-3","article-title":"The physiopathological significance of ceruloplasmin. A possible therapeutic approach","volume":"60","author":"Floris","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.arcmed.2012.05.006_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-510X(00)00295-1","article-title":"Increased lipid peroxidation in the brains of aceruloplasminemia patients","volume":"175","author":"Yoshida","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.arcmed.2012.05.006_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03033302","article-title":"Disturbance of iron metabolism in Parkinson\u2019s disease \u2014 ultrasonography as a biomarker","volume":"9","author":"Berg","year":"2006","journal-title":"Neurotox Res"},{"key":"10.1016\/j.arcmed.2012.05.006_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.31887\/DCNS.2011.13.2\/kwiedemann","article-title":"Biomarkers in development of psychotropic drugs","volume":"13","author":"Wiedemann","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.arcmed.2012.05.006_bib7","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.2174\/092986711797200417","article-title":"New therapeutic strategy for mood disorders","volume":"18","author":"Crupi","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.arcmed.2012.05.006_bib8","first-page":"282","article-title":"Increased plasma ceruloplasmin levels in schizophrenia","volume":"18","author":"Virit","year":"2008","journal-title":"Bull Clin Psychopharmacol"},{"key":"10.1016\/j.arcmed.2012.05.006_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1744-9081-4-52","article-title":"High ceruloplasmin levels are associated with obsessive compulsive disorder: a case control study","volume":"18","author":"Virit","year":"2008","journal-title":"Behav Brain Funct"},{"key":"10.1016\/j.arcmed.2012.05.006_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0165-0327(92)90066-F","article-title":"Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness","volume":"24","author":"Maes","year":"1992","journal-title":"J Affect Disord"},{"key":"10.1016\/j.arcmed.2012.05.006_bib11","first-page":"260","article-title":"Effect of antidepressant treatment on acute phase protein levels in patients with depression","volume":"8","author":"Bekaro\u011flu","year":"1997","journal-title":"Turk Psikiyatri Derg"},{"key":"10.1016\/j.arcmed.2012.05.006_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.arcmed.2012.05.006_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/comp.2001.19756","article-title":"Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale","volume":"42","author":"Akdemir","year":"2001","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.arcmed.2012.05.006_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000012290","article-title":"Outcome definitions and predictors in depression","volume":"67","author":"Tedlow","year":"1998","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.arcmed.2012.05.006_bib15","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/clinchem\/44.11.2313","article-title":"Automated measurement of serum ferroxidase activity","volume":"44","author":"Erel","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.arcmed.2012.05.006_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clinbiochem.2003.10.014","article-title":"A novel automated method to measure total antioxidant response against potent free radical reactions","volume":"37","author":"Erel","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.arcmed.2012.05.006_bib17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1440-1819.2009.02015.x","article-title":"Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile","volume":"63","author":"Pazvantoglu","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.arcmed.2012.05.006_bib18","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1373\/clinchem.2005.052688","article-title":"Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice","volume":"51","author":"Twomey","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.arcmed.2012.05.006_bib19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2001-15184","article-title":"Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence","volume":"34","author":"Schmid","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.arcmed.2012.05.006_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.schres.2006.05.027","article-title":"Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia","volume":"86","author":"Wolf","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.arcmed.2012.05.006_bib21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1471-4159.2007.04602.x","article-title":"Copper induced oxidation of serotonin: analysis of products and toxicity","volume":"102","author":"Jones","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2012.05.006_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"Belmaker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2012.05.006_bib23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00702-003-0008-8","article-title":"Regional serotonin transporter availability and depression are correlated in Wilson\u2019s disease","volume":"110","author":"Hesse","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.arcmed.2012.05.006_bib24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00415-003-1039-7","article-title":"The degree of depression in Hamilton rating scale is correlated with the density of presynaptic serotonin transporters in 23 patients with Wilson\u2019s disease","volume":"250","author":"Eggers","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.arcmed.2012.05.006_bib25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1440-1819.2009.02004.x","article-title":"Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment","volume":"63","author":"Cumurcu","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.arcmed.2012.05.006_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.npbr.2011.11.001","article-title":"The relationship of oxidative metabolism to treatment response in major depression: a biological basis for treatment duration","volume":"18","author":"Selek","year":"2012","journal-title":"Neurol Psychiatr Brain Res"},{"key":"10.1016\/j.arcmed.2012.05.006_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pnpbp.2007.10.002","article-title":"Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidant-antioxidant status","volume":"32","author":"Selek","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"key":"10.1016\/j.arcmed.2012.05.006_bib28","series-title":"Kaplan & Sadock\u2019s Comprehensive Text Book of Psychiatry","first-page":"1649","article-title":"Mood disorders","author":"Akiskal","year":"2009"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440912001312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440912001312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:39:48Z","timestamp":1759261188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440912001312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0188440912001312"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2012.05.006","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No Effect of Antidepressant Treatment on Elevated Serum Ceruloplasmin Level in Patients with First-Episode Depression: A Longitidunal Study","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2012.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}